US 2019/0315846 A1Published application

Antibodies to Human Alpha-Synuclein

AssigneeThe Michael J. Fox Foundation for Parkinson's Research

InventorsTerina N. Martinez, Kuldip Dave, Sonal Das

Life of this patent

Estimating the term…

Abstract

Described a monoclonal antibody to human alpha-synuclein, and the use of that antibody in treating Parkinson's disease.

Claims23

Dependent claims

An isolated rabbit monoclonal antibody that specifically binds the C-terminal consensus motif YQDYEP of human α-synuclein

Dependencies are inferred from the claim text.

Facts

Application: 16/466,713Filed 7 Dec 2017
Priority: 12 Dec 2016
Published: 17 Oct 2019
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

C07K 16/18
Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies: against material from animals or humans
A61P 25/16
For treating abnormal movements, e.g. chorea, dyskinesia: anti-Parkinson drugs
C07K 2317/24
Characterized by taxonomic origin: containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
C07K 2317/34
Characterized by aspects of specificity or valency: identification of a linear epitope shorter than 20 amino acid residues or of a conformational…

Family

Application62/432,761Us provisional application · filed 12 Dec 2016
US 2019/0315846 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results